Drug details

Anzemet Injection (dolasetron mesylate injection)

type of Antiemetics, Selective 5-HT3 Antagonist

Anzemet Injection (dolasetron mesylate) is an antinauseant and antiemetic used to prevent nausea and vomiting associated with cancer chemotherapy, and to prevent and treat postoperative nausea and/or vomiting.

This drug may have the following side effects:

• hives,
• difficulty breathing,
• swelling of your face, lips, tongue, or throat,
• nausea,
• vomiting,
• fever,
• lightheadedness,
• fainting,
• agitation,
• overactive reflexes,
• slow heart rate,
• swelling in your hands or feet,
• hallucinations,
• slow breathing,
• fast or pounding heartbeats,
• little or no urinating,
• weak pulse,
• headache with chest pain and severe dizziness,
• diarrhea, and
• loss of coordination

The following drugs are related to Anzemet Injection, either as a replacement or used together:

• Barhemsys (amisulpride injection, for intravenous use)
• Aponvie (aprepitant injectable emulsion)
• Emend Capsules (aprepitant capsules)
• Emend Injection (fosaprepitant dimeglumine injection)
• Focinvez (fosaprepitant injection)
• Varubi (rolapitant tablets)

The following supplements are related to Anzemet Injection, and may be used together with the drug:

• Artichoke (s.)
• Ginger (s.)
• Ipecac (s.)